---
title: "Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs | LEXX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283839233.md"
description: "Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs | LEXX Stock News"
datetime: "2026-04-23T05:05:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283839233.md)
  - [en](https://longbridge.com/en/news/283839233.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283839233.md)
---

# Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs | LEXX Stock News

Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs | LEXX Stock News

### Related Stocks

- [LEXX.US](https://longbridge.com/en/quote/LEXX.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [LEXXW.US](https://longbridge.com/en/quote/LEXXW.US.md)

## Related News & Research

- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)
- [<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>](https://longbridge.com/en/news/286807703.md)